📈 Stocks & Economy🌐 Global
Next-Gen Weight Loss Drugs Are Coming — and They Work Better Than Ozempic
MarketWatch·Sunday, 7 June 2026
A new drug called Retatrutide helped people lose a remarkable amount of weight in clinical trials — more than today's popular GLP-1 drugs like Ozempic or Wegovy. It also improved sleep apnea and knee pain as side effects of the weight loss. A wave of similar next-generation drugs is now in development.
Why It Matters
Weight-loss drugs are already reshaping global healthcare spending and the food industry. Better, more effective versions could accelerate that disruption significantly.
🔒 Potential Impact + source link
Subscribe to unlock the impact analysis and original source for every story.
More from Stocks & Economy
- Nasdaq's Biggest-Ever Point Drop: What Indian Investors Should Know
- US Jobs Boom Kills Rate Cut Dreams — and That's a Problem for India Too
- China Is Poaching AI Talent From the US — India's Tech Sector Should Pay Attention
- Goldman Sachs Shifts Bet to Mainland China AI — What It Means for India's Market